DARPA aims to build robotic combat surgeons

Published: Tuesday, September 9, 2025 at 9:18 am

DARPA Unveils Robotic Combat Surgeon Program to Combat Battlefield Trauma

The Defense Advanced Research Projects Agency (DARPA) has initiated a new program, Medics Autonomously Stopping Hemorrhage (MASH), aimed at revolutionizing battlefield trauma care. The program focuses on developing autonomous robotic systems to address a critical challenge: non-compressible torso hemorrhage, a leading cause of preventable death among warfighters.

The MASH program seeks to create robotic systems capable of autonomously locating and stopping internal bleeding with minimal human intervention. The goal is to stabilize patients for up to 48 hours, providing sufficient time for evacuation to advanced surgical care. The program manager, Dr. Adam Willis, emphasized the importance of providing warfighters with the best possible chance of survival, highlighting the potential to save lives by addressing injuries that are often survivable with timely surgical intervention.

The MASH concept integrates advanced sensors, artificial intelligence, and robotic tools into a system designed to navigate the complex internal environment of the human body. The system will pinpoint the source of bleeding and deploy life-saving interventions in harsh combat environments. The program aims to create a system as user-friendly as automated external defibrillators (AEDs), allowing non-specialists to administer life-saving care.

The three-year program will be conducted in two phases. The first phase will focus on integrating advanced sensors with robotic platforms to detect internal bleeding. The second phase will involve developing autonomous software to control robotic tools and halt hemorrhaging. DARPA aims to advance both trauma care protocols and robotic surgical capabilities, pushing the boundaries of field medicine.

BNN's Perspective:

While the development of autonomous robotic surgeons raises ethical considerations, the potential to save lives on the battlefield is undeniable. The MASH program represents a significant investment in improving the survivability of warfighters and could potentially revolutionize trauma care in civilian settings as well. Careful consideration of the ethical implications and rigorous testing will be crucial as this technology develops.

Keywords: DARPA, robotic surgery, battlefield trauma, autonomous robots, internal bleeding, hemorrhage, MASH program, warfighters, trauma care, artificial intelligence, medical technology, field medicine, surgical capabilities

Full Story